TRLPC: Merck looks for $8B bridge for Cubist acquisition
December 15, 2014 at 16:24 PM EST
NEW YORK, Dec 15 (Reuters) - Merck & Co Inc is approaching banks about an $8 billion, 364-day bridge loan that will back the drugmaker's plans to acquire Cubist Pharmaceuticals Inc, sources told Thomson Reuters LPC.
